Relay Therapeutics RLAY
NASDAQ RLAY
$18.36 +0.67 (+3.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Research & Development (2019 - 2026)

Updated

Relay Therapeutics' Research & Development came in at $76.48 million for Q2 2026, up 19.7% from $63.9 million a year earlier and up 8.4% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Research & Development (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Relay Therapeutics reported Research & Development of $270.72 million, down 4.1% year-over-year; for FY2025, it was $261.38 million, down 18.1% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • Going back by year, Research & Development was $319.09 million in FY2024 (-3.3%), $330.02 million in FY2023 (+34.0%), $246.36 million in FY2022 (+42.7%) and $172.65 million in FY2021 (+72.9%).
  • The Q2 2026 figure represents the highest quarterly Research & Development since Q3 2024.
  • Year-over-year, Research & Development increased in 1 of the last eight quarters, with an average decline of 9.2%.
  • The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 84.5%), and the weakest in Q2 2025 (a decline of 30.5%).
  • Business Quant data shows RLAY's Research & Development at $70.56 million (Q1 2026), $55.42 million (Q4 2025) and $68.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Relay Therapeutics 3.87 Bn 3.87 Bn - 76.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.48 Mn
Mar 31, 2026 70.56 Mn
Dec 31, 2025 55.42 Mn
Sep 30, 2025 68.26 Mn
Jun 30, 2025 63.90 Mn
Mar 31, 2025 73.81 Mn
Dec 31, 2024 68.08 Mn
Sep 30, 2024 76.62 Mn
Jun 30, 2024 91.99 Mn
Mar 31, 2024 82.40 Mn
Dec 31, 2023 77.50 Mn
Sep 30, 2023 81.49 Mn
Jun 30, 2023 88.20 Mn
Mar 31, 2023 82.83 Mn
Dec 31, 2022 67.28 Mn
Sep 30, 2022 66.90 Mn
Jun 30, 2022 60.51 Mn
Mar 31, 2022 51.67 Mn
Dec 31, 2021 51.91 Mn
Sep 30, 2021 44.97 Mn
API Access

Relay Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=RLAY&period=max&api_key=YOUR_API_KEY